David Lawrence, Chief of Business Operations at ACORDA THERAPEUTICS INC (ACOR), sold 39,026 shares at $41.06 ($1.6M) on 2015-12-18, disclosed to the SEC on 2015-12-22.
Scheduled sale ($1.6M) by Chief of Business Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.62 | 38,506 | $1.6M | 98.7% |
| 2 | $41.06 | 520 | $21K | 1.3% |
| Total | $40.63 avg | 39,026 | $1.6M | 100% |
| Filing → |
| ACOR | SELL | 2018-12-06 | $102K | — | Filing → |
| ACOR | SELL | 2018-06-13 | $208K | — | Filing → |
| ACOR | SELL | 2018-06-11 | $1.3M | — | Filing → |